This most recent twist inside the Lykos Therapeutics saga threatens A serious overhaul of the business’s method and course, with Musk ally and billionaire investor Antonio Gracias showing to choose to choose the organization again towards its nonprofit drug growth roots and a more Doblinite philosophy.In several respects, the for-gain copyright f